Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video
Whitepapers

Resources

patient access to biosimilars
Increase Patient Access to Lower-Cost Biosimilar Medicines
July 27, 2021
The Biosimilars Council - Doctors with hands in the middle
Organizations Thank Rep. Schrader, Kinzinger for Introducing the BIOSIM Act
July 1, 2021
Increasing Provider Reimbursement for Biosimilars Will Lead to Greater Adoption
June 28, 2021
Biosimilar Medicines Equal More Accessible Care for America’s Patients
June 11, 2021
IQVIA Report Highlights Options to Boost U.S. Provider Use of Biosimilars
May 7, 2021
A new IQVIA report found that biosimilar adoption is more favorable where relative reimbursement to physicians is higher for the biosimilar.
Access! 2021 Is Coming. Here’s What You Need to Know
April 20, 2021
Access!, AAM’s annual meeting for the generics and biosimilars industry, brings policymakers, influential speakers and industry leaders together to share knowledge and ideas. This year virtual Access! is May 26-27.

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

Recent Tweets

Biosimilars CouncilFollow1,99910,183

Biosimilars Council works to ensure a positive environment for patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/0jAeG0TOPj

Biosimilars Council
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
24 Sep 1441417189928538112

Thanks to these three bills in Congress, American patients are one step closer to greater access to lifesaving #biosimilars.

✅ The BIOSIM Act

✅ The Increasing Access to Biosimilars Act

✅ The Ensuring Access to Lower-Cost Medicines for Seniors Act

https://bit.ly/3i7Klhi

Twitter feed video.
Image for the Tweet beginning: Thanks to these three bills
Reply on Twitter 1441417189928538112Retweet on Twitter 1441417189928538112Like on Twitter 14414171899285381121Twitter 1441417189928538112
Load More...